Hemodynamics: Heterogeneous Endothelial Gene Expression

血流动力学:异质内皮基因表达

基本信息

  • 批准号:
    6853195
  • 负责人:
  • 金额:
    $ 28.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

The endothelium is well recognized as a mechanotranduction interface influencing vessel physiology and pathology. The prevalence of atherogenesis in regions associated with complex disturbed flows in vivo has long been recognized yet the factors that predispose such sites and potentiate preferential atherosclerosis there are poorly understood. We propose that hemodynamic forces determine the susceptibility to atherosclerosis by regulation of the regional phenotype of endothelium at such sites. Preliminary profiling studies in the normal adult porcine aorta using microarray have shown differences in endothelial gene expression between areas prone to develop atherosclerotic lesions (disturbed flow) and those areas that are typically spared. Project 5 will address the hypothesis that at lesion-susceptible locations, the endothelial phenotype is in an equilibrium state that is primed to develop atherosclerosis by expression of pro-inflammatory genes but is protected by the up-regulation of anti-oxidant mechanisms and other genes that prevent the initiation/early development of atherosclerosis. Exposure to one or more risk factors (additional to hemodynamics) is proposed to be necessary for imbalances that lead to the development of vascular pathology. In a collaboration with the Center for Devices and Radiological Health animal facility at the FDA Laurel, MD, we will conduct the first multi-gene expresssion studies of endothelium in vivo in defined hemodynamic locations. Regional endothelial phenotypes will be defined in normal adult porcine arteries, and the effects of the important risk factors hypercholesterolemia, gender, and hormonal manipulations upon atherosclerosis-primed regions will be determined. The critical role of hemodynamics in regional susceptibility will be tested by creating flow disturbances in the common carotid artery, a location that is normally exposed to undisturbed laminar flow and which is resistant to atherogenesis; we propose that a susceptible phenotype will result from such intervention. The effects of hemodynamic forces upon anti-oxidant, coagulation, inflammatory and other gene classifications will be measured in vitro where transcription profiles of porcine endothelial cells exposed to oscillating and unidirectional flow will be analyzed. Using small interfering RNA, specific gene 'knock-downs' will be created (gene silencing) to determine the effect upon hemodynamic responses in vitro including perturbations of the phenotype as evaluated by microarray profiling with follow-up protein and proteomic studies.
内皮细胞被公认为影响血管生理和病理的机械传导界面。人们早已认识到与体内复杂扰动流动相关的区域中动脉粥样硬化的普遍性,但对易患此类部位并增强优先动脉粥样硬化的因素却知之甚少。我们认为,血流动力学的力量决定了动脉粥样硬化的易感性,在这些网站的内皮细胞的区域表型的调节。利用微阵列对正常成年猪主动脉进行的初步分析研究表明,不同区域的内皮基因表达存在差异 易于发展动脉粥样硬化病变(血流紊乱)和那些通常不受影响的区域。项目5将阐述以下假设:在病变易感部位,内皮表型处于平衡状态,通过促炎基因的表达引发动脉粥样硬化,但受到抗氧化机制和其他阻止动脉粥样硬化起始/早期发展的基因上调的保护。暴露于一种或多种风险因素(除血流动力学外)被认为是导致血管病理发展的失衡所必需的。在与FDA月桂,MD的设备和放射卫生动物设施中心的合作中,我们将进行第一次多基因 内皮细胞在确定的血流动力学位置的体内表达研究。将在正常成年猪动脉中定义区域内皮表型,并确定重要风险因素高胆固醇血症、性别和激素操作对动脉粥样硬化致敏区域的影响。血流动力学在区域易感性中的关键作用将通过在颈总动脉中产生流动扰动来进行测试,颈总动脉是一个通常暴露于不受干扰的层流并且抵抗动脉粥样硬化形成的位置;我们建议这种干预将导致易感表型。 将在体外测量血液动力学对抗氧化剂、凝血、炎症和其他基因分类的影响,其中将分析暴露于振荡和单向流的猪内皮细胞的转录谱。使用小干扰RNA,将产生特异性基因“敲低”(基因沉默),以确定对体外血液动力学反应的影响,包括通过微阵列分析与后续蛋白质和蛋白质组学研究评价的表型扰动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Francis Davies其他文献

Peter Francis Davies的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Francis Davies', 18)}}的其他基金

Training Program in Biomedical Imaging and Informational Sciences
生物医学成像和信息科学培训项目
  • 批准号:
    8874220
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Training Program in Biomedical Imaging and Informational Sciences
生物医学成像和信息科学培训项目
  • 批准号:
    9539668
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Training Program in Biomedical Imaging and Informational Sciences
生物医学成像和信息科学培训项目
  • 批准号:
    9113002
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Mitigation of stent-mediated pathology by streamlined geometry
通过简化的几何结构减轻支架介导的病理学
  • 批准号:
    7740376
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Hemodynamics: Heterogeneous Endothelial Gene Expression
血流动力学:异质内皮基因表达
  • 批准号:
    7796926
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Mitigation of stent-mediated pathology by streamlined geometry
通过简化的几何结构减轻支架介导的病理学
  • 批准号:
    7916775
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Training Program in Biomedical Imaging and Informational Sciences
生物医学成像和信息科学培训项目
  • 批准号:
    8666955
  • 财政年份:
    2009
  • 资助金额:
    $ 28.21万
  • 项目类别:
Core A-- Genomics Core
核心A——基因组学核心
  • 批准号:
    7001736
  • 财政年份:
    2003
  • 资助金额:
    $ 28.21万
  • 项目类别:
HEMODYNAMICS--HETEROGENEOUS ENDOTHELIAL GENE EXPRESSION
血流动力学--异质内皮基因表达
  • 批准号:
    6591067
  • 财政年份:
    2002
  • 资助金额:
    $ 28.21万
  • 项目类别:
Cell and molecular studies in cardiovascular engineering
心血管工程中的细胞和分子研究
  • 批准号:
    6340423
  • 财政年份:
    2001
  • 资助金额:
    $ 28.21万
  • 项目类别:

相似海外基金

Signaling mediators of CCL2/CCR2 and natural product discovery
CCL2/CCR2 信号传导介质和天然产物发现
  • 批准号:
    10623540
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity
剖析花生四烯酸代谢途径在 PM 诱导的心脏代谢毒性的消退与进展中的作用
  • 批准号:
    10716093
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Improving exercise rehabilitation efficacy and outcomes in Veterans with peripheral artery disease: Targeting oxidative stress and inflammation
提高患有外周动脉疾病的退伍军人的运动康复效果和结果:针对氧化应激和炎症
  • 批准号:
    10638943
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Targeted Mitochondrial Delivery Systems for Vascular Interventions
用于血管干预的靶向线粒体输送系统
  • 批准号:
    10905155
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Regulation of plasma LDL and HDL by microRNA-541-3p
microRNA-541-3p 对血浆 LDL 和 HDL 的调节
  • 批准号:
    10733641
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Endothelial Cell Respiration in Atherosclerotic Plaque Erosion
动脉粥样硬化斑块糜烂中的内皮细胞呼吸
  • 批准号:
    10586227
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Mito-Frail 试验:MitoQ 对体弱老年人的血管舒张、活动能力和认知能力的影响
  • 批准号:
    10572663
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Altered High-Density Lipoprotein function in Patients with Idiopathic Inflammatory Myopathies
特发性炎症性肌病患者高密度脂蛋白功能的改变
  • 批准号:
    10739224
  • 财政年份:
    2023
  • 资助金额:
    $ 28.21万
  • 项目类别:
Targeted drug delivery for the treatment of cardiovascular disease and its clinical complications
靶向给药治疗心血管疾病及其临床并发症
  • 批准号:
    10371510
  • 财政年份:
    2022
  • 资助金额:
    $ 28.21万
  • 项目类别:
Advanced Non-invasive Imaging in the Investigation of Aortic Stenosis Pathobiology
主动脉瓣狭窄病理学研究中的先进无创成像
  • 批准号:
    10693935
  • 财政年份:
    2022
  • 资助金额:
    $ 28.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了